RE: Analyst Recommendation Jason knows this company well as anyone following the company for a long time will know. He's saying the same thing that I've said for years, that the shorts are engaged in a sector play and have not done extensive due diligence on HCG itself. The risk for us is that if the housing market does take a real dump, the share price of HCG could get dragged down even if the effect on their actual business is modest (2008 revisited).